Evidence map›Paper›PMID 38158550›Full record

ReviewJournal of extracellular vesicles2024

Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies.

Ursula S Sandau, Setty M Magaña, Júlia Costa, John P Nolan, Tsuneya Ikezu, Laura J Vella, Hannah K Jackson, Lissette Retana Moreira, Paola Loreto Palacio, Andrew F Hill and 13 more

Erratum issuedAbstract readReview
In one paragraph

Review in Journal of extracellular vesicles, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration.International journal of molecular sciences · 2025
    Review
  16. Article
  17. ICAM-5: A Novel Marker for Neuronally Derived Extracellular Vesicles.bioRxiv : the preprint server for biology · 2025
    Article
  18. Review
  19. Article
  20. The functional role of exosomalTranslational cancer research · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Ursula S SandauDepartment of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-3646-7089
Setty M MagañaCenter for Clinical and Translational Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID 0000-0002-2450-3206
Júlia CostaInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, Oeiras, Portugal.ORCID 0000-0001-7782-6319
John P NolanScintillon Institute for Biomedical and Bioenergy Research, San Diego, California, USA.ORCID 0000-0001-5845-3764
Tsuneya IkezuDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, USA.ORCID 0000-0002-3979-8596
Laura J VellaDepartment of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.ORCID 0000-0002-1869-6291
Hannah K JacksonDepartment of Pathology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-4090-0885
Lissette Retana MoreiraDepartment of Parasitology, Faculty of Microbiology, University of Costa Rica, San José, Costa Rica, Central America.ORCID 0000-0001-5215-582X
Paola Loreto PalacioCenter for Clinical and Translational Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.
Andrew F HillInstitute for Health and Sport, Victoria University, Melbourne, Victoria, Australia.ORCID 0000-0001-5581-2354
Joseph F QuinnDepartment of Neurology, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0001-7305-2256
Kendall R Van Keuren-JensenNeurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona, USA.ORCID 0000-0001-8833-6323
Trevor J McFarlandDepartment of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-4275-4930
Joanna PaladeNeurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona, USA.
Eric A SribnickDepartment of Neurosurgery, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0002-1691-8559
Huaqi SuThe Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Victoria, Australia.ORCID 0000-0002-0334-8868
Kostas VekrellisBiomedical Research Foundation Academy of Athens, Athens, Greece.ORCID 0000-0001-5702-9953
Beth CoyleChildren's Brain Tumour Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, University of Nottingham, Nottingham, Nottinghamshire, UK.ORCID 0000-0003-2957-1862
You YangScintillon Institute for Biomedical and Bioenergy Research, San Diego, California, USA.ORCID 0000-0003-0574-7827
Juan M Falcón-PerezExosomes Laboratory, Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance, Derio, Spain.ORCID 0000-0003-3133-0670
Rienk NieuwlandLaboratory of Experimental Clinical Chemistry, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-5671-3400
Julie A SaugstadDepartment of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-2996-9611
International Society for Extracellular Vesicles Cerebrospinal Fluid Task ForceDepartment of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, USA.

Funding

Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KEVIN M DUFF, Lisa C Silbert · 2020 to 2026
$28.6M
Exosome-mediated propagation of pathogenic tau proteinRF1AG054199 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2016 to 2021
$5.0M
Establishing MicroRNA Biomarkers for Diagnosing Alzheimer's Disease & Predicting ProgressionRF1AG059392 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI SAUGSTAD, JULIE ANNE · 2019 to 2019
$3.4M
Molecular characterization of extracellular vesicles for the spread of misfolded tau proteinR01AG067763 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2021 to 2025
$3.1M
Human Cerebrospinal Fluid Extracellular Vesicles: Utility as Disease Specific Biomarkers and Impact on Alzheimer's Disease PathologyR01AG079356 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI JULIE Anne SAUGSTAD · 2023 to 2026
$3.0M
Targeting emerging P2RX7 signaling pathways in animal models of Alzheimer's diseaseR01AG066429 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2020 to 2024
$2.0M
NIA NIH HHS P30 AG066518NIA NIH HHS R01 AG066429NIA NIH HHS R01 AG067763NIA NIH HHS R01 AG079356NIA NIH HHS RF1 AG054199NIA NIH HHS RF1 AG059392
6 · The paper itself

Abstract

Cerebrospinal fluid (CSF) is a clear, transparent fluid derived from blood plasma that protects the brain and spinal cord against mechanical shock, provides buoyancy, clears metabolic waste and transports extracellular components to remote sites in the brain. Given its contact with the brain and the spinal cord, CSF is the most informative biofluid for studies of the central nervous system (CNS). In addition to other components, CSF contains extracellular vesicles (EVs) that carry bioactive cargoes (e.g., lipids, nucleic acids, proteins), and that can have biological functions within and beyond the CNS. Thus, CSF EVs likely serve as both mediators of and contributors to communication in the CNS. Accordingly, their potential as biomarkers for CNS diseases has stimulated much excitement for and attention to CSF EV research. However, studies on CSF EVs present unique challenges relative to EV studies in other biofluids, including the invasive nature of CSF collection, limited CSF volumes and the low numbers of EVs in CSF as compared to plasma. Here, the objectives of the International Society for Extracellular Vesicles CSF Task Force are to promote the reproducibility of CSF EV studies by providing current reporting and best practices, and recommendations and reporting guidelines, for CSF EV studies. To accomplish this, we created and distributed a world-wide survey to ISEV members to assess methods considered 'best practices' for CSF EVs, then performed a detailed literature review for CSF EV publications that was used to curate methods and resources. Based on responses to the survey and curated information from publications, the CSF Task Force herein provides recommendations and reporting guidelines to promote the reproducibility of CSF EV studies in seven domains: (i) CSF Collection, Processing, and Storage; (ii) CSF EV Separation/Concentration; (iii) CSF EV Size and Number Measurements; (iv) CSF EV Protein Studies; (v) CSF EV RNA Studies; (vi) CSF EV Omics Studies and (vii) CSF EV Functional Studies.

Indexed as

Extracellular VesiclesBiomarkersBrainProteinsReproducibility of ResultsBiomarkersProteinsbiomarkersbraincentral nervous systemcerebrospinal fluidexosomeextracellular vesiclerecommendations and reporting

Identifiers

PMID38158550
PMCPMC10756860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.